Review




Structured Review

MicroFluidic Systems multi-channel microfluidic systems
Multi Channel Microfluidic Systems, supplied by MicroFluidic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi-channel+microfluidic+systems/channel+based+microfluidic+systems/pm40136988-245-2-3
Average 90 stars, based on 1 article reviews
multi-channel microfluidic systems - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

Fluorescence:

Article Title: Line-Monitoring, Hyperspectral Fluorescence Setup for Simultaneous Multi-Analyte Biosensing
Article Snippet: In order to demonstrate the biomedical application of this line-monitoring, hyperspectral fluorescence biosensor, we designed a model experiment to detect short oligonucleotides for identification of bacteria using multi-channel microfluidic systems. shows the preparation of DNA probes.

Article Title: Analysis of Personalized Cardiovascular Drug Therapy: From Monitoring Technologies to Data Integration and Future Perspectives.
Article Snippet: Additionally, with multi-channel microfluidic systems, it is possible to investigate Biosensors 2025, 15, 191 12 of 37 interactions between drugs and various proteins, enabling a comprehensive evaluation of drug safety [168,169].

Article Title: Analysis of Personalized Cardiovascular Drug Therapy: From Monitoring Technologies to Data Integration and Future Perspectives
Article Snippet: Additionally, with multi-channel microfluidic systems, it is possible to investigate interactions between drugs and various proteins, enabling a comprehensive evaluation of drug safety [ , ].

Bacteria:

Article Title: Line-Monitoring, Hyperspectral Fluorescence Setup for Simultaneous Multi-Analyte Biosensing
Article Snippet: In order to demonstrate the biomedical application of this line-monitoring, hyperspectral fluorescence biosensor, we designed a model experiment to detect short oligonucleotides for identification of bacteria using multi-channel microfluidic systems. shows the preparation of DNA probes.

Article Title: Analysis of Personalized Cardiovascular Drug Therapy: From Monitoring Technologies to Data Integration and Future Perspectives.
Article Snippet: Additionally, with multi-channel microfluidic systems, it is possible to investigate Biosensors 2025, 15, 191 12 of 37 interactions between drugs and various proteins, enabling a comprehensive evaluation of drug safety [168,169].

Article Title: Analysis of Personalized Cardiovascular Drug Therapy: From Monitoring Technologies to Data Integration and Future Perspectives
Article Snippet: Additionally, with multi-channel microfluidic systems, it is possible to investigate interactions between drugs and various proteins, enabling a comprehensive evaluation of drug safety [ , ].



Similar Products

90
MicroFluidic Systems multi-channel microfluidic systems
Multi Channel Microfluidic Systems, supplied by MicroFluidic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi-channel+microfluidic+systems/channel+based+microfluidic+systems/pm40136988-245-2-3
Average 90 stars, based on 1 article reviews
multi-channel microfluidic systems - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
FLUIGENT Inc multi-channel microfluidic flow control system mfcs
a Schematic of the <t>microfluidic</t> dynamic single-cell screening for PTC (colored circles), based on induction of the SOS DNA damage response (light-blue arrow) and decrease in cell-to-cell variation (gradient arrow). The growth and phenotypic transition of rod-shaped bacteria over time ( t ) is also illustrated. The main PTC hit M06 is shown as a blue circle. b Schematic of the expected mode of action and drug potentiation effect of M06. Blunt arrows indicate inhibition and sharp arrows indicate induction. Blue and gray sharp arrows show the entry of M06 into the cell and the exit of its main metabolites, respectively. Bioprocessing of M06 is carried out by unknown nitroreductases (NR) and methyltransferases (MT). Nitroreduction decreases M06 potency and is a likely source of oxidative stress . Reactive oxygen species (ROS) damage lipids, DNA, and may affect NAT (lilac flat arrows). M06 is presumed to inhibit NAT, thus affecting the composition and stability of the mycobacterial cell envelope and impairing the energy metabolism (black flat arrows). NAT might otherwise be implicated in oxidative stress tolerance (orange flat arrow). M06 inhibits DNA gyrase causing DNA breaks. The presence of single-stranded DNA triggers the SOS response. Overall, impairment of cellular energy, lipid, and DNA metabolism might induce additional oxidative stress, which further affects different macromolecules and processes in the cell. Metabolic remodeling and induction of oxidative stress response help the cell countering oxidative damage . This includes the upregulation of the catalase peroxidase KatG, which activates the anti-tubercular drug INH . NAT inhibition by M06 further contributes to INH activation, destabilizing the cell integrity. On the other hand, M06-mediated inhibition of negative DNA supercoiling in the presence of the anti-tubercular drug RIF, which inhibits the RNA polymerase, further impairs DNA topology, preventing both DNA replication and transcription , with lethal consequences for the mycobacterial cell.
Multi Channel Microfluidic Flow Control System Mfcs, supplied by FLUIGENT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi-channel+microfluidic+systems/microfluidic+flow+control+system+mfcs+ez/pmc11099131-456-6-12
Average 90 stars, based on 1 article reviews
multi-channel microfluidic flow control system mfcs - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


a Schematic of the microfluidic dynamic single-cell screening for PTC (colored circles), based on induction of the SOS DNA damage response (light-blue arrow) and decrease in cell-to-cell variation (gradient arrow). The growth and phenotypic transition of rod-shaped bacteria over time ( t ) is also illustrated. The main PTC hit M06 is shown as a blue circle. b Schematic of the expected mode of action and drug potentiation effect of M06. Blunt arrows indicate inhibition and sharp arrows indicate induction. Blue and gray sharp arrows show the entry of M06 into the cell and the exit of its main metabolites, respectively. Bioprocessing of M06 is carried out by unknown nitroreductases (NR) and methyltransferases (MT). Nitroreduction decreases M06 potency and is a likely source of oxidative stress . Reactive oxygen species (ROS) damage lipids, DNA, and may affect NAT (lilac flat arrows). M06 is presumed to inhibit NAT, thus affecting the composition and stability of the mycobacterial cell envelope and impairing the energy metabolism (black flat arrows). NAT might otherwise be implicated in oxidative stress tolerance (orange flat arrow). M06 inhibits DNA gyrase causing DNA breaks. The presence of single-stranded DNA triggers the SOS response. Overall, impairment of cellular energy, lipid, and DNA metabolism might induce additional oxidative stress, which further affects different macromolecules and processes in the cell. Metabolic remodeling and induction of oxidative stress response help the cell countering oxidative damage . This includes the upregulation of the catalase peroxidase KatG, which activates the anti-tubercular drug INH . NAT inhibition by M06 further contributes to INH activation, destabilizing the cell integrity. On the other hand, M06-mediated inhibition of negative DNA supercoiling in the presence of the anti-tubercular drug RIF, which inhibits the RNA polymerase, further impairs DNA topology, preventing both DNA replication and transcription , with lethal consequences for the mycobacterial cell.

Journal: Nature Communications

Article Title: Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapy

doi: 10.1038/s41467-024-48269-2

Figure Lengend Snippet: a Schematic of the microfluidic dynamic single-cell screening for PTC (colored circles), based on induction of the SOS DNA damage response (light-blue arrow) and decrease in cell-to-cell variation (gradient arrow). The growth and phenotypic transition of rod-shaped bacteria over time ( t ) is also illustrated. The main PTC hit M06 is shown as a blue circle. b Schematic of the expected mode of action and drug potentiation effect of M06. Blunt arrows indicate inhibition and sharp arrows indicate induction. Blue and gray sharp arrows show the entry of M06 into the cell and the exit of its main metabolites, respectively. Bioprocessing of M06 is carried out by unknown nitroreductases (NR) and methyltransferases (MT). Nitroreduction decreases M06 potency and is a likely source of oxidative stress . Reactive oxygen species (ROS) damage lipids, DNA, and may affect NAT (lilac flat arrows). M06 is presumed to inhibit NAT, thus affecting the composition and stability of the mycobacterial cell envelope and impairing the energy metabolism (black flat arrows). NAT might otherwise be implicated in oxidative stress tolerance (orange flat arrow). M06 inhibits DNA gyrase causing DNA breaks. The presence of single-stranded DNA triggers the SOS response. Overall, impairment of cellular energy, lipid, and DNA metabolism might induce additional oxidative stress, which further affects different macromolecules and processes in the cell. Metabolic remodeling and induction of oxidative stress response help the cell countering oxidative damage . This includes the upregulation of the catalase peroxidase KatG, which activates the anti-tubercular drug INH . NAT inhibition by M06 further contributes to INH activation, destabilizing the cell integrity. On the other hand, M06-mediated inhibition of negative DNA supercoiling in the presence of the anti-tubercular drug RIF, which inhibits the RNA polymerase, further impairs DNA topology, preventing both DNA replication and transcription , with lethal consequences for the mycobacterial cell.

Article Snippet: The platform was controlled from the multi-channel Microfluidic Flow Control System (MFCS, Fluigent), via the MAESFLOW Control software (Fluigent): channel (C) 1 drove the FL inlet; C2 drove the CL inlet; C3 drove the reservoirs injecting lids; and C4 drove the FL outlet.

Techniques: Bacteria, Inhibition, Bioprocessing, Activation Assay